CVS Health Corporation

80.05-1.50-1.84%Vol 11.30M1Y Perf 24.22%
Aug 5th, 2021 16:00 DELAYED
BID80.00 ASK80.05
Open81.36 Previous Close81.55
Pre-Market- After-Market80.05
 - -  - -%
Target Price
95.73 
Analyst Rating
Moderate Buy 1.59
Potential %
19.59 
Finscreener Ranking
★★★     49.94
Insiders Trans % 3/6/12 mo.
-100/-87/-93 
Value Ranking
★★+     49.70
Insiders Value % 3/6/12 mo.
-100/-99/-100 
Growth Ranking
★★     45.93
Insiders Shares Cnt. % 3/6/12 mo.
-100/-99/-100 
Income Ranking
★★★     44.97
Price Range Ratio 52W %
70.04 
Earnings Rating
Strong Buy
Market Cap105.39B 
Earnings Date
4th Aug 2021
Alpha-0.01 Standard Deviation0.08
Beta0.83 

Today's Price Range

79.3481.75

52W Range

55.3690.61

5 Year PE Ratio Range

-89.2023.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Week
-2.80%
1 Month
-1.39%
3 Months
-4.36%
6 Months
10.90%
1 Year
24.22%
3 Years
23.08%
5 Years
-17.79%
10 Years
148.51%

TickerPriceChg.Chg.%
CVS80.05-1.5000-1.84
AAPL147.060.11000.07
GOOG2 738.8018.23000.67
MSFT289.523.01001.05
XOM57.200.36000.63
WFC46.990.84001.82
JNJ173.690.33000.19
FB362.974.05001.13
GE103.020.11000.11
JPM153.151.91001.26
Financial StrengthValueIndustryS&P 500US Markets
0.50
0.90
0.52
1.16
4.50
Leverage Ratio 3.30
ProfitabilityValueIndustryS&P 500US Markets
18.30
4.70
6.40
3.10
2.15
RevenueValueIndustryS&P 500US Markets
205.71B
156.25
10.16
9.18
DividendsValueIndustryS&P 500US Markets
2.43
2.00
37.22
5.02
Payout ratio36.00
Earnings HistoryEstimateReportedSurprise %
Q02 20212.072.4216.91
Q01 20211.722.0418.60
Q04 20201.241.304.84
Q03 20201.341.6623.88
Q02 20201.932.6436.79
Q01 20201.631.9117.18
Q04 20191.681.732.98
Q03 20191.771.843.95
Earnings Per EndEstimateRevision %Trend
6/2021 QR2.0710.11Positive
9/2021 QR1.86-7.92Negative
12/2021 FY7.661.46Positive
12/2022 FY8.262.61Positive
Next Report Date-
Estimated EPS Next Report2.07
Estimates Count9
EPS Growth Next 5 Years %6.70
Volume Overview
Volume11.30M
Shares Outstanding1.32B
Shares Float1.31B
Trades Count91.87K
Dollar Volume482.49M
Avg. Volume6.69M
Avg. Weekly Volume8.42M
Avg. Monthly Volume5.59M
Avg. Quarterly Volume6.29M

CVS Health Corporation (NYSE: CVS) stock closed at 80.05 per share at the end of the most recent trading day (a -1.84% change compared to the prior day closing price) with a volume of 11.32M shares and market capitalization of 105.39B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 300000 people. CVS Health Corporation CEO is Karen S. Lynch.

The one-year performance of CVS Health Corporation stock is 24.22%, while year-to-date (YTD) performance is 17.2%. CVS stock has a five-year performance of -17.79%. Its 52-week range is between 55.36 and 90.61, which gives CVS stock a 52-week price range ratio of 70.04%

CVS Health Corporation currently has a PE ratio of 14.70, a price-to-book (PB) ratio of 1.53, a price-to-sale (PS) ratio of 0.53, a price to cashflow ratio of 7.00, a PEG ratio of 2.32, a ROA of 3.21%, a ROC of 6.12% and a ROE of 10.88%. The company’s profit margin is 2.15%, its EBITDA margin is 6.40%, and its revenue ttm is $205.71 Billion , which makes it $156.24 revenue per share.

Of the last four earnings reports from CVS Health Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.07 for the next earnings report. CVS Health Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for CVS Health Corporation is Moderate Buy (1.59), with a target price of $95.73, which is +19.59% compared to the current price. The earnings rating for CVS Health Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CVS Health Corporation has a dividend yield of 2.43% with a dividend per share of $2.00 and a payout ratio of 36.00%.

CVS Health Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 7.92, ATR14 : 1.63, CCI20 : -58.70, Chaikin Money Flow : 0.09, MACD : -0.09, Money Flow Index : 41.75, ROC : 1.09, RSI : 44.05, STOCH (14,3) : 42.16, STOCH RSI : 0.00, UO : 53.24, Williams %R : -57.84), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CVS Health Corporation in the last 12-months were: Alan Lotvin (Option Excercise at a value of $1 716 346), Alan Lotvin (Sold 40 112 shares of value $2 937 020 ), Alan M. Lotvin (Option Excercise at a value of $3 432 692), Alan M. Lotvin (Sold 68 729 shares of value $5 107 406 ), Daniel P. Finke (Option Excercise at a value of $1 751 420), Daniel P. Finke (Sold 37 594 shares of value $3 255 640 ), Edward J. Ludwig (Buy at a value of $216 000), Eva C. Boratto (Option Excercise at a value of $1 402 743), Eva C. Boratto (Sold 23 787 shares of value $1 802 507 ), James D. Clark (Option Excercise at a value of $397 452), James D. Clark (Sold 5 350 shares of value $406 600 ), Jonathan C. Roberts (Option Excercise at a value of $5 455 337), Jonathan C. Roberts (Sold 73 433 shares of value $5 470 024 ), Joshua Flum (Option Excercise at a value of $750 242), Joshua Flum (Sold 21 460 shares of value $1 502 200 ), Larry J. Merlo (Option Excercise at a value of $49 877 858), Larry J. Merlo (Sold 667 086 shares of value $50 136 870 ), Lisa Bisaccia (Option Excercise at a value of $3 740 798), Lisa Bisaccia (Sold 50 354 shares of value $3 877 258 ), Thomas M. Moriarty (Option Excercise at a value of $13 024 323), Thomas M. Moriarty (Sold 215 577 shares of value $16 405 675 ), Troyen A. Brennan (Option Excercise at a value of $8 138 534), Troyen A. Brennan (Sold 135 925 shares of value $11 022 740 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
10 (62.50 %)
10 (62.50 %)
11 (61.11 %)
Moderate Buy
2 (12.50 %)
2 (12.50 %)
2 (11.11 %)
Hold
4 (25.00 %)
4 (25.00 %)
5 (27.78 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.59
Moderate Buy
1.59
Moderate Buy
1.64

CVS Health Corporation

CVS Health Corp provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing about 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with over 23 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

CEO: Karen S. Lynch

Telephone: +1 401 765-1500

Address: One CVS Drive, Woonsocket 02895, RI, US

Number of employees: 300 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

51%49%

Bearish Bullish

59%41%

Bearish Bullish

61%39%

TipRanks News for CVS

Thu, 05 Aug 2021 19:55 GMT Analysts Are Bullish on These Consumer Goods Stocks: CVS Health (CVS), Roku (ROKU)

- Copyright © 2021, TipRanks. All rights reserved.

Wed, 04 Aug 2021 13:03 GMT CVS Health Raises Guidance on Higher-Than-Expected Q2 Results

- Copyright © 2021, TipRanks. All rights reserved.

News

Stocktwits